Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Objectives: Transverse myelitis (TM) and acute disseminated encephalomyelitis (ADEM) are debilitating neurological conditions. We aimed to examine in-hospital mortality and readmissions in patients hospitalized with TM and/or ADEM. Methods: In this retrospective study, we analyzed the Nationwide Readmissions Database from 2010 to 2020, excluding 2015, to identify index hospitalizations for TM and/or ADEM. Patients were stratified according to in-hospital mortality status. We used the Pearson chi-square test and Wilcoxon rank-sum test to compare baseline characteristics, while multivariable logistic regression analysis was used to identify predictors of in-hospital mortality. Results: Of 50,357 patients hospitalized with TM and/or ADEM, 1236 (2.5%) did not survive index hospitalization. Nonsurvivors were older with longer lengths of stay and a higher comorbidity burden. Among those ≥45 years, there was a trend towards increased odds of in-hospital mortality. Infection-related factors were associated with increased odds of in-hospital mortality, including streptococcal infection (odds ratio [OR]: 5.45 [1.07–27.68], p = 0.04) and coronavirus disease 2019 (OR: 4.54 [2.51–8.19], p < 0.001). Stroke (OR 2.71 [2.11–3.48], p < 0.001) and congestive heart failure (OR 2.17 [1.66–2.85], p < 0.001) emerged as the strongest predictors amongst chronic comorbidities. Over the study period, 5301 (11.8%) patients were readmitted to the hospital within 30 days. Conclusions: In patients with TM and/or ADEM, in-hospital mortality was associated with older age, greater comorbidity burden, and concurrent infections, particularly COVID-19 and streptococcal infections. These findings highlight opportunities for prevention, early detection, and management strategies to improve outcomes for patients with TM and/or ADEM.
Source: Clinics and Practice
Institutions: Rice University, The University of Texas at Austin, Guthrie Robert Packer Hospital, Baylor College of Medicine, The University of Texas Health Science Center at Houston, University Hospitals of Cleveland, Case Western Reserve University, The University of Texas Health Science Center at Tyler
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,930
OpenAlex ID: W7236092233
